Inventor · disambiguated record
Tatsuki Koike
Also filed as: KOIKE TATSUKI
48 granted patents·11 pending applications·164 citations·filing 2007–2025
98Inventor score
Files withTAKEDA PHARMACEUTICALS CO37TAKEDA PHARMACEUTICAL10FUJIFILM CORP5KOIKE TATSUKI4UCHIKAWA OSAMU3
Top patents by PatentIndex Score
59 records- 0197US10428023B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·22 cites·1 claims
- 0296US10584097B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Mar 10, 2020·14 cites·1 claims
- 0395US11028048B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 8, 2021·8 cites·9 claims
- 0494US11440883B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 13, 2022·3 cites·1 claims
- 0593US8648079B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2012·Granted Feb 11, 2014·13 cites·3 claims
- 0691US9440990B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Sep 13, 2016·7 cites·8 claims
- 0791US8871766B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Oct 28, 2014·8 cites·3 claims
- 0891US8865717B2Heterocyclic compoundsTAKEDA PHARMACEUTICAL·Filed 2013·Granted Oct 21, 2014·8 cites·3 claims
- 0990US9193709B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Nov 24, 2015·8 cites·18 claims
- 1089US11059780B2Substituted pyrrolidine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jul 13, 2021·4 cites·13 claims
- 1188US11987586B1Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonistsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted May 21, 2024·1 cites·16 claims
- 1287US11319286B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 3, 2022·4 cites·10 claims
- 1387US11174272B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Nov 16, 2021·1 cites·16 claims
- 1487US11034700B2Substituted pyrrolidine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Jun 15, 2021·4 cites·13 claims
- 1586US10106556B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Oct 23, 2018·8 cites·20 claims
- 1686US9586930B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Mar 7, 2017·3 cites·12 claims
- 1786US2024360080A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1884US11655241B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted May 23, 2023·2 cites·15 claims
- 1984US10202376B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Feb 12, 2019·4 cites·6 claims
- 2083US9643957B2Heterocyclic compounds having cholesterol 24-hydroxylase activityTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted May 9, 2017·6 cites·12 claims
- 2183US8030337B2Tricyclic compound and pharmaceutical use thereofTAKEDA PHARMACEUTICAL·Filed 2007·Granted Oct 4, 2011·4 cites·3 claims
- 2281US10550129B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Feb 4, 2020·1 cites·8 claims
- 2381US10273245B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Apr 30, 2019·1 cites·11 claims
- 2481US8236837B2Tricyclic compound and pharmaceutical use thereofUCHIKAWA OSAMU·Filed 2011·Granted Aug 7, 2012·4 cites·3 claims
- 2580US12421188B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 23, 2025·0 cites·19 claims
- 2680US12415782B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 16, 2025·0 cites·19 claims
- 2780US12404237B2Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivativesTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 2, 2025·0 cites·19 claims
- 2879US10144743B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 4, 2018·1 cites·11 claims
- 2978US9598398B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Mar 21, 2017·4 cites·14 claims
- 3077US8349879B2Tricyclic compound and pharmaceutical use thereofTAKEDA PHARMACEUTICAL·Filed 2011·Granted Jan 8, 2013·2 cites·3 claims
- 3176US9624170B24-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (MAGL) inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Apr 18, 2017·3 cites·16 claims
- 3276US8552037B2Tricyclic compound and pharmaceutical use thereofTAKEDA PHARMACEUTICAL·Filed 2012·Granted Oct 8, 2013·2 cites·17 claims
- 3376US2023063805A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 3475US9296746B2Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2013·Granted Mar 29, 2016·3 cites·13 claims
- 3575US2021276949A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 3674US10717748B21-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseasesTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 21, 2020·0 cites·15 claims
- 3774US10548877B2Aromatic ring compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Feb 4, 2020·2 cites·11 claims
- 3873US8273761B2Tricyclic compound and medical use thereofUCHIKAWA OSAMU·Filed 2007·Granted Sep 25, 2012·2 cites·10 claims
- 3973US8247429B2Tricyclic compound and pharmaceutical use thereofUCHIKAWA OSAMU·Filed 2007·Granted Aug 21, 2012·2 cites·10 claims
- 4072US10112956B2Heterocyclic compounds having cholesterol 24-hydroxylase activityTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 30, 2018·1 cites·11 claims
- 4172US8110585B2Bicyclic compound and pharmaceutical use thereofKOIKE TATSUKI·Filed 2008·Granted Feb 7, 2012·2 cites·17 claims
- 4267US9624184B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Apr 18, 2017·1 cites·10 claims
- 4366US9963443B2Radiolabeled compoundsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted May 8, 2018·1 cites·20 claims
- 4463US8895591B2Tricyclic compound and pharmaceutical use thereofTAKEDA PHARMACEUTICAL·Filed 2013·Granted Nov 25, 2014·0 cites·12 claims
- 4563US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 4662US2025299388A1Image processing device, image processing method, image processing program, learning device, learning method, and learning programFUJIFILM CORP·Filed 2025·Application pending·0 cites
- 4757US2025299470A1Image processing device, image processing method, and image processing programFUJIFILM CORP·Filed 2025·Application pending·0 cites
- 4857US2014350260A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 4956US2025308024A1Image processing device, image processing method, image processing program, learning device, learning method, and learning programFUJIFILM CORP·Filed 2025·Application pending·0 cites
- 5055US2025295367A1Image processing device, image processing method, and image processing programFUJIFILM CORP·Filed 2025·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Tatsuki Koike files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →